← All news
Company Announcement · AIM: TLM

Management Changes

Management Changes

Ovoca Bio PLC

03 March 2025

Ovoca Bio PLC

3 March 2025

Ovoca Bio plc

("Ovoca" or the "Company")

Management Changes

Dublin, Ireland, 3 March 2025 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, is pleased to announce the appointment of Ms. Leah O'Donovan as its Chief Financial Officer with immediate effect. Ms. O'Donovan is a professional accountant with over 15 years' experience working in the accounting and financial services industries. Prior to joining Ovoca, she was a Senior Financial Controller at Grant Thornton, Senior Financial Accountant at CNP Santander Insurance, and worked at such institutions as MetLife and Maples Fiduciary Services. Timothy McCutcheon, Ovoca's CEO, said " We welcome Leah to our team and look forward to working with her for the benefit of all Ovoca stakeholders. I would like to thank Dmitriy Nikitashenko for his service and wish him well in his future endeavors ."

The role of Chief Financial Officer is not a Board position at present.

End

For further information:

Ovoca Bio plc

Timothy McCutcheon (Chief Executive)

Tel +353 1 661 9819

info@ovocabio.com

Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)

Ivan Murphy / Daragh O'Reilly

Tel: +353 1 679 6363

Talisman Metals PLC is admitted to trading on AIM under the ticker TLM. For further information, please contact us.